Literature DB >> 7747825

Extracorporeal cardiopulmonary life support with heparin-bonded circuitry in the resuscitation of massively injured trauma patients.

M J Perchinsky1, W B Long, J G Hill, J A Parsons, J B Bennett.   

Abstract

BACKGROUND: Patients who have massive but potentially survivable injuries frequently die from complications of hypovolemia, hypoxemia, hypothermia, metabolic acidosis, and coagulopathy. Emergency cardiopulmonary bypass has been unsuccessful in preventing such deaths because it involves systemic anticoagulation that exacerbates coagulopathy. PATIENTS AND METHODS: A simplified extracorporeal cardiopulmonary life support (ECLS) system was assembled consisting of a centrifugal pump head, heat exchanger, membranous oxygenator, percutaneous cannulas, and heparin-bonded circuitry. The entire system has heparin-bonded surfaces. Patients were resuscitated with the system after femoral vein-femoral artery cannulation. ECLS was used to resuscitate massively injured patients who were deteriorating despite maximal conventional therapy.
RESULTS: While receiving maximal conventional therapy, 6 patients developed hypothermia, metabolic acidosis, and coagulopathy causing pulmonary hemorrhaging and hypoxemia from severe underlying lung injuries. ECLS with heparin-bonded circuitry provided cardiopulmonary support and rewarming while physicians addressed coagulopathies and surgical bleeding and assessed survivability. Three patients survived.
CONCLUSIONS: ECLS with heparin-bonded circuitry offers supplemental capability in the resuscitation and cardiopulmonary support of selected massively injured patients while their primary injuries are being evaluated and treated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7747825     DOI: 10.1016/S0002-9610(99)80201-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

Review 1.  Extracorporeal life support in critically ill adults.

Authors:  Corey E Ventetuolo; Christopher S Muratore
Journal:  Am J Respir Crit Care Med       Date:  2014-09-01       Impact factor: 21.405

2.  Extracorporeal membrane oxygenation for accidental deep hypothermia-current challenges and future perspectives.

Authors:  Piotr Mazur; Sylweriusz Kosiński; Paweł Podsiadło; Anna Jarosz; Roman Przybylski; Radosław Litiwnowicz; Jacek Piątek; Janusz Konstanty-Kalandyk; Robert Gałązkowski; Tomasz Darocha
Journal:  Ann Cardiothorac Surg       Date:  2019-01

3.  Application of percutaneous cardiopulmonary support for cardiac tamponade following blunt chest trauma: two case reports.

Authors:  Seon Hee Kim; Seunghwan Song; Yeong Dae Kim; Jeong Su Cho; Chung Won Lee; Jong Geun Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-10-09

4.  Successful use of extracorporeal life support after double traumatic tracheobronchial injury in a patient with severe acute asthma.

Authors:  Xavier Valette; Aurélie Desjouis; Massimo Massetti; Jean-Luc Hanouz; Philippe Icard
Journal:  Pulm Med       Date:  2011-11-02

5.  Extracorporeal life support in pediatric trauma: a systematic review.

Authors:  Thaddeus Puzio; Patrick Murphy; Josh Gazzetta; Michael Phillips; Bryan A Cotton; Jennifer L Hartwell
Journal:  Trauma Surg Acute Care Open       Date:  2019-09-13

6.  Long-term extracorporeal membrane oxygenation after severe blunt traumatic lung injury in a child.

Authors:  Ok Jeong Lee; Yang Hyun Cho; Jinwook Hwang; Inae Yoon; Young-Ho Kim; Joongbum Cho
Journal:  Acute Crit Care       Date:  2017-02-10

7.  Severe traumatic injury during long duration spaceflight: Light years beyond ATLS.

Authors:  Andrew W Kirkpatrick; Chad G Ball; Mark Campbell; David R Williams; Scott E Parazynski; Kenneth L Mattox; Timothy J Broderick
Journal:  J Trauma Manag Outcomes       Date:  2009-03-25

8.  Extracorporeal lung support in trauma patients with severe chest injury and acute lung failure: a 10-year institutional experience.

Authors:  Michael Ried; Thomas Bein; Alois Philipp; Thomas Müller; Bernhard Graf; Christof Schmid; David Zonies; Claudius Diez; Hans-Stefan Hofmann
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.